Insider Transactions in Q2 2023 at Fibrogen Inc (FGEN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
791
-0.73%
|
$12,656
$16.53 P/Share
|
|
Jun 14
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
6,250
-1.29%
|
$106,250
$17.06 P/Share
|
|
Jun 13
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
6,250
-2.51%
|
$106,250
$17.6 P/Share
|
|
Jun 09
2023
|
Suzanne Blaug |
SELL
Open market or private sale
|
Direct |
8,520
-11.83%
|
$144,840
$17.12 P/Share
|
|
Jun 09
2023
|
Aoife Brennan |
SELL
Open market or private sale
|
Direct |
4,733
-7.51%
|
$80,461
$17.13 P/Share
|
|
Jun 09
2023
|
Benjamin Cravatt |
SELL
Open market or private sale
|
Direct |
3,944
-6.22%
|
$67,048
$17.13 P/Share
|
|
Jun 09
2023
|
Jeffrey L Edwards |
SELL
Open market or private sale
|
Direct |
7,889
-9.89%
|
$134,113
$17.13 P/Share
|
|
Jun 08
2023
|
Jeffrey William Henderson Director |
SELL
Open market or private sale
|
Direct |
7,000
-8.66%
|
$119,000
$17.28 P/Share
|
|
Jun 08
2023
|
Maykin Ho |
SELL
Open market or private sale
|
Direct |
8,520
-11.12%
|
$144,840
$17.24 P/Share
|
|
Jun 07
2023
|
Suzanne Blaug |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+17.86%
|
-
|
|
Jun 07
2023
|
Aoife Brennan |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+20.23%
|
-
|
|
Jun 07
2023
|
Benjamin Cravatt |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+20.23%
|
-
|
|
Jun 07
2023
|
James A Schoeneck |
SELL
Open market or private sale
|
Indirect |
7,100
-8.78%
|
$127,800
$18.03 P/Share
|
|
Jun 07
2023
|
James A Schoeneck |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+22.37%
|
-
|
|
Jun 07
2023
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+16.53%
|
-
|
|
Jun 07
2023
|
Jeffrey L Edwards |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+16.53%
|
-
|
|
Jun 07
2023
|
Gerald Lema |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+22.37%
|
-
|
|
Jun 07
2023
|
Maykin Ho |
BUY
Grant, award, or other acquisition
|
Direct |
8,289
+17.16%
|
-
|
|
Jun 07
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
1,758
-0.78%
|
$29,886
$17.04 P/Share
|
|
Jun 07
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
3,633
-0.48%
|
$61,761
$17.04 P/Share
|
|
Jun 07
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,785
-1.23%
|
$28,560
$17.0 P/Share
|
|
Jun 07
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,897
-1.16%
|
$151,249
$17.04 P/Share
|
|
Jun 07
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,042
-1.24%
|
$34,714
$17.04 P/Share
|
|
Jun 02
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,090
-0.66%
|
$19,620
$18.83 P/Share
|
|
Apr 10
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,869
-0.49%
|
$35,511
$19.52 P/Share
|
|
Apr 04
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,182
-5.24%
|
$165,276
$18.78 P/Share
|
|
Apr 04
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Open market or private sale
|
Direct |
6,590
-2.54%
|
$118,620
$18.78 P/Share
|